CTNM logo
CTNM

Contineum Therapeutics Inc

Pharmaceuticals

Contineum Therapeutics Inc (CTNM) Earnings

Last reported
May 14, 2026
EPS estimate
-$0.54
EPS actual
Revenue est.
Revenue actual